Videos

Healthy development of the gut microbiome after birth supports short- and long-term health. Human milk oligosaccharides, or HMOs, are important modulators of early gut microbiome development and partly explain the positive effect of breastfeeding on gut microbiome trajectories.

In this video, you will see the latest findings from a clinical study supporting the beneficial effects of 5 specific HMOs on the trajectories and composition of the gut microbiome from infancy through toddlerhood. The positive results for infants born by caesarean section are also shown.

You can see more results of this clinical study on other parameters of gut development in a different video - https://www.nestlenutrition-institute.org/videos/hmos-and-gut-development-new-clinical-evidence

Not all tasks are equal, and this video talks about managing situations based on their unique circumstances. So, next time something comes up, you’ll know if you will pursue it immediately, Plan it, Prioritize it, or Park it indefinitely. It’s all about taking the time to analyze each task, so you can get on with the most important duties and not sweat the rest.

Human Milk Oligosaccharides (HMOs) occur in different structures with different functions in breastmilk. With the advances in research and technology, biotechnologically obtained HMOs or bio-HMOs are now being produced and supplemented in infant formula, and are a point of interest in randomized clinical trials to support the clinical relevance of specific bio-HMOs in formula-fed babies. This lecture by Prof. Hania Szajewska discusses updates regarding findings on naturally occuring HMOs, and bio-HMOs, its functions on immunity and cognition, and ways moving forward to address current gaps in these researches.

The gut microbiome is a system that undergoes rapid changes especially in infancy. This development rate then shifts to a slower pace as it turns into the fully-developed adult microbiome achieved in later childhood. The early life microbiome (ELM) is an indicator of long-term health given its impacts on the different facets of growth and development, and it is found that Human Milk Oligossachardes (HMOs) are on of the main driving factors of the development of the ELM. In the studies discussed by Shillay Kumar Dogra, he details how the test groups given formula with HMO supplementation -- either 2-HMO or 5-HMO -- caught up better with the microbiome trajectory of breastfed infants or the microbiome-age predictor. This lecture shows the results in the microbiome-related endpoints in randomized controlled trials of formula-fed infants given formula that contains blends of HMOs in greater detail.

The “First 1000 Days of Life” refers to a crucial period, comprising pregnancy and the first two postnatal years, which may have a lasting impact in terms of programming effects for later health. These are closely related to the environment on the child, including nutrition.

In this lecture by Prof. Berthold Koletzko, learn more about the trans-disciplinary collaboration of clinicians that links clinical characterization with biomarkers, to be able to make connections with occurrences in the human body for programming in relation to diet, activity, environment, and genetic predisposition.

The COVID-19 virus has had a global effect, with almost 300 million confirmed cases by the year 2022. While this has hid mild disease and mortality for cases below the age of 19, this virus has had a multitude of effects on children indirectly, one of the biggest impacts being on their nutritional status.

This pandemic has aggravated malnutrition on both ends of the spectrum. Undernutrition was brought about by poverty, food security, and effects of the disease in decrease nutrient intake, while overnutrition was caused by the decrease in physical activities, and negative changes in food habits.

This lecture by Prof. Sanja Kolaček discusses the latest data on the incidence of malnutrition as an effect of the pandemic, its possible long-term implications, how malnutrition affects the prognosis of COVID-19, and ways to move forward for treatment strategies.

Human milk is the optimal food for the growing infant, with a wide array of benefits for both the mother and the baby for immediate and long-term health. This remains to be the best choice for feeding as it adapts to the infant’s development stage as well as external factors to help protect the baby.

There is still a lot to unfold with the complex structures of human milk, as it holds to potential to also be bioactive delivery systems to a growing infant. This talk by Aristea Binia, PhD, allows the discussion for future strides in the field of human milk research, especially in its composition and function, and possible global reference development to be able to maximize the nutritional applications of human milk for the mother and the child.